Get the Stockscreener App
2.10
4.00%
0.10
Acurx Pharmaceuticals Inc stock is traded at $2.10, with a volume of 26,511.
It is up +4.00% in the last 24 hours and down -41.24% over the past month.
Acurx Pharmaceuticals Inc is a late-stage biopharmaceutical company focused on developing a new class of small-molecule antibiotics for difficult-to-treat bacterial infections. Its approach is to develop antibiotic candidates with a Gram-positive selective spectrum (GPSS) that block the active site of the Gram-positive specific bacterial enzyme deoxyribonucleic acid (DNA) polymerase IIIC (pol IIIC), inhibiting DNA replication and Gram-positive bacterial cell death. Its research and development pipeline includes antibiotic product candidates targeting Gram-positive bacteria, including Clostridioides difficile, methicillin-resistant Staphylococcus aureus, vancomycin-resistant Enterococcus, and drug-resistant Streptococcus pneumoniae and B. anthracis. It operates in a single segment.
See More
Previous Close:
$2.00
Open:
$2.12
24h Volume:
26,511
Relative Volume:
0.01
Market Cap:
$5.88M
Revenue:
-
Net Income/Loss:
$-7.97M
P/E Ratio:
-0.5395
EPS:
-3.8923
Net Cash Flow:
$-6.79M
1W Performance:
+5.58%
1M Performance:
-41.24%
6M Performance:
-58.40%
1Y Performance:
-69.50%
1-Day Range:
$2.0401
$2.12
1-Week Range:
$1.94
$2.2999
52-Week Range:
$1.3259
$21.00
Acurx Pharmaceuticals Inc Stock (ACXP) Company Profile
Name
Acurx Pharmaceuticals Inc
Sector
Industry
Phone
917-533-1469
Address
259 LIBERTY AVENUE, STATEN ISLAND
Compare ACXP vs VRTX, REGN, ARGX, ALNY, ONC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ACXP
Acurx Pharmaceuticals Inc
|
2.06 | 5.71M | 0 | -7.97M | -6.79M | -3.8923 |
VRTX
Vertex Pharmaceuticals Inc
|
428.25 | 107.87B | 12.32B | 4.34B | 3.19B | 16.86 |
REGN
Regeneron Pharmaceuticals Inc
|
720.03 | 73.63B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
811.70 | 49.42B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
304.18 | 40.20B | 3.71B | 313.75M | 465.38M | 2.2571 |
ONC
Beone Medicines Ltd Adr
|
315.00 | 33.06B | 5.36B | 287.73M | 924.18M | 2.5229 |
Acurx Pharmaceuticals Inc Stock (ACXP) Latest News
1.65M ACXP warrant shares registered for resale by Acurx (NASDAQ: ACXP) - Stock Titan
Acurx (NASDAQ: ACXP) files S-1 to register 1.3M Lincoln Park resale shares - Stock Titan
Mouse study links Acurx antibiotics to MRSA drop, gut microbes preserved - Stock Titan
Can Acurx Pharmaceuticals (ACXP) climb 226.3% to reach the level Wall Street analysts expect? - MSN
ACXP Stock Price, Quote & Chart | ACURX PHARMACEUTICALS INC (NASDAQ:ACXP) - ChartMill
Replay to follow Acurx CEO's virtual A.G.P. healthcare fireside chat - Stock Titan
Is Acurx Pharmaceuticals (ACXP) stock outpacing its medical peers this year? - MSN
Acurx Pharmaceuticals, Inc. To Present at The Market Movers Investor Summit - The Globe and Mail
Acurx Pharmaceuticals announces up to $7.1M offering - MSN
ACXP Forecast, Price Target & Analyst Ratings | ACURX PHARMACEUTICALS INC (NASDAQ:ACXP) - ChartMill
ACXP (Acurx Pharmaceuticals Inc.) posts far stronger Q4 2025 EPS than analyst estimates, but shares fall 4.42 percent today.Consensus Beat - UBND thành phố Hải Phòng
Acurx (ACXP) director Carl Sailer awarded 2,150 stock options at $2.36 - Stock Titan
Acurx (NASDAQ: ACXP) director gets 2,150 stock options grant - Stock Titan
Acurx Pharmaceuticals (ACXP) director awarded 2,150 stock options as board pay - Stock Titan
Acurx Pharmaceuticals (ACXP) director awarded 2,150 stock options at $2.36 strike - Stock Titan
Acurx Pharmaceuticals (ACXP) director receives 2,150 stock options grant - Stock Titan
Acurx Pharmaceuticals (ACXP) director awarded 37,100 stock options at $2.36 - Stock Titan
Acurx Pharmaceuticals (ACXP) CEO awarded 37,100 stock options at $2.36 - Stock Titan
CFO of Acurx (NASDAQ: ACXP) receives 25,900 stock options award - Stock Titan
Acurx Pharmaceuticals to Discuss First Quarter 2026 Financial Results on May 12, 2026 Conference Call and Provide Business Update - Weekly Voice
Biopharmaceutical company Acurx Pharmaceuticals announced plans to hold an investor conference call on May 12, 2026, during which it will provide a detailed overview of its financial results for the first quarter of 2026. - Bitget
Acurx Pharmaceuticals to discuss first quarter 2026 financial results on May 12, 2026 conference call and provide business update - marketscreener.com
Acurx Pharmaceuticals To Discuss First Quarter 2026 Financial Results On May 12, 2026 Conference Call And Provide Business Update - TradingView
Acurx will discuss Q1 results and a business update on May 12 - Stock Titan
Acurx Pharmaceuticals | CORRESP: CORRESP - Moomoo
Acurx Pharmaceuticals closes $2.5M financing with warrants By Investing.com - Investing.com Australia
Crude Oil Gains Over 2%; PepsiCo Posts Upbeat Q1 Earnings - Sahm
Dow Surges Over 100 Points; US Initial Jobless Claims Fall - Sahm
Acurx Pharmaceuticals, Inc. announces closing of up to $7.1 million registered direct offering priced at-the-market under Nasdaq rules - marketscreener.com
Acurx Pharmaceuticals closes $2.5M financing with warrants - Investing.com
Acurx Pharmaceuticals, Inc. Announces Closing of up to $7.1 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules - ChartMill
Acurx Pharmaceuticals raises $2.5M in direct offering By Investing.com - Investing.com South Africa
Acurx Pharmaceuticals, Inc. Announces up to $ - Moomoo
Acurx Pharmaceuticals Secures New Financing to Advance Pipeline - TipRanks
Acurx Pharmaceuticals (NASDAQ: ACXP) sells 816,068 shares; raises ~$2.2M - Stock Titan
Acurx Pharmaceuticals raises $2.5M in direct offering - Investing.com
Acurx Pharmaceuticals | 424B5: Prospectus - Moomoo
Acurx Pharmaceuticals (ACXP) raises $2.5M with warrants for up to $4.6M more - Stock Titan
Acurx lines up $2.5M now, another $4.6M if warrants are used - Stock Titan
12 Health Care Stocks Moving In Wednesday's Pre-Market Session - Sahm
Market Leaders: What analysts say about Acurx Pharmaceuticals Inc stock2026 Outlook & Daily Profit Focused Stock Screening - baoquankhu1.vn
New to The Street Broadcasts on Bloomberg Television at 6:30 PM EST Featuring IGC Pharma (IGC), Vivos Therapeutics (VVOS), Acurx Pharmaceuticals (ACXP), and Equinox Gold (EQX) - Scott Coop
New to The Street Broadcasts on Bloomberg TV, Featuring IGC, VVOS, ACXP, and EQX - National Today
Acurx Pharmaceuticals Inc Stock (ACXP) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.78%
3.01%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):